Navigation Links
Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1

-1, the most treatment-resistant type of HCV, and the majority of patients (74%) had high baseline viral load ( > 800,000 IU/ml), a well-established negative predictive factor for SVR. Patients received daily injections of omega interferon (25 mcg) for up to 48 weeks. The endpoints for this clinical trial were early viral response (EVR), defined as a 2-log reduction in HCV RNA after 12 weeks of treatment, and SVR, defined as undetectable HCV RNA 24 weeks after the end of 48 weeks of treatment. Response rates are presented in the table below:


         HCV RNA Results               Omega IFN + RBV   Omega IFN Alone


    (LOQ= 50 IU/ml)                          N=67              N=35


    Early Viral Response (EVR)               84%               60%

    p= 0.014


    Sustained Viral Response(SVR)            36%               6%

    p= 0.001


With this study, Intarcia also took a step toward testing its hypothesis that maintaining continuous drug levels through daily administration of omega interferon may minimize side effects when compared to current interferon therapies. This study to date has shown that omega interferon is well tolerated with only two discontinuations due to adverse events. Results of this Phase 2 study suggest a favorable overall safety profile with no substantial safety issues being identified. Normalization of serum ALT, a marker of reduced liver inflammation, occurred in 100% of patients achieving SVR and no patients receiving omega interferon with ribavirin experienced relapse during 24 weeks of follow-up after completing 48 weeks of treatment.

Alice Leung, President and Chief Executive Officer of Intarcia stated, "We are developing omega interferon to improve the treatment of HCV by offering a more convenient, potentially safer and more efficacious therapy. Based on the data so far, we believe that a continuous release formulation of omega interferon has the potential to become an important therapy for HCV pat
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Intarcia Therapeutics Announces Presentation of Final Results From a Phase 2 Combination Study for the Treatment of Hepatitis C at the Digestive Disease Week Conference
2. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
3. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
4. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
5. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
6. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
7. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
8. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
9. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
10. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
11. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
Post Your Comments:
(Date:9/15/2014)... 2014  Decision Resources Group,s new Manhattan ... that online information and other value-added services ... their offering and support physicians. Physicians who ... rely on websites, mobile apps and other ... physicians are looking to manufacturers to provide ...
(Date:9/15/2014)... MINNEAPOLIS , Sept. 15, 2014 ... a non-profit professional association serving more than 4,500 ... released its 2015 SCALENDAR, which chronicles corporate fines ... compliance and ethics professionals have a ready reference ... "We developed the SCALENDAR to help ...
(Date:9/15/2014)... , Sept. 15, 2014 Research and ... Worldwide Market for In Vitro Diagnostic Tests, 9th Edition" ... covers the entirety of the clinical testing market and all ... Used by Top IVD Companies For Business Planning. ... based on the market events of 2013 and early 2014. ...
Breaking Medicine Technology:Physician device decision-makers show strong demand for device manufacturer digital content and support 2Physician device decision-makers show strong demand for device manufacturer digital content and support 3More than $55 billion in fines and settlements added by SCCE to its 2015 Corporate Scandal Calendar 2The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition 2The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition 3
... COLLEGEVILLE, Pa., April 03, 2007 /PRNewswire-FirstCall/ --,Wyeth Pharmaceuticals, ... a,re- analysis of pooled data from both hormone ... published today in the,Journal of the American Medical ... coronary heart disease for women who,initiate hormone therapy ...
... superior sustained pain-free results compared to,sumatriptan, RESEARCH ... 03, 2007,/PRNewswire-FirstCall/ -- -- Findings from two ... sufferers demonstrated that,Trexima(TM) provided superior headache relief ... placebo, and two through 24-hour sustained,pain-free results ...
Cached Medicine Technology:New Analysis of Data from WHI Provides Reassurance With Respect to,Coronary Heart Disease For Newly Menopausal Women Considering,Hormone Therapy 2New Analysis of Data from WHI Provides Reassurance With Respect to,Coronary Heart Disease For Newly Menopausal Women Considering,Hormone Therapy 3New Analysis of Data from WHI Provides Reassurance With Respect to,Coronary Heart Disease For Newly Menopausal Women Considering,Hormone Therapy 4New Analysis of Data from WHI Provides Reassurance With Respect to,Coronary Heart Disease For Newly Menopausal Women Considering,Hormone Therapy 5New Analysis of Data from WHI Provides Reassurance With Respect to,Coronary Heart Disease For Newly Menopausal Women Considering,Hormone Therapy 6Trexima (Sumatriptan/Naproxen Sodium) Superior Efficacy Data,Published in JAMA 2Trexima (Sumatriptan/Naproxen Sodium) Superior Efficacy Data,Published in JAMA 3Trexima (Sumatriptan/Naproxen Sodium) Superior Efficacy Data,Published in JAMA 4Trexima (Sumatriptan/Naproxen Sodium) Superior Efficacy Data,Published in JAMA 5
(Date:9/16/2014)... Beverly Hills, CA (PRWEB) September 16, 2014 ... to announce the launch of ACLsurgeryLA.com , a ... various ACL injuries. As an avid sports lover ... best options for treatment and recovery from injuries to ... this opportunity to offer patients a resource dedicated specifically ...
(Date:9/16/2014)... NY (PRWEB) September 16, 2014 Registration ... Run For The Warriors®, a 10K, 5K, and 1-mile ... The race is sponsored by Local 338 RWDSU/UFCW, the ... will begin at the Town of Babylon Town Hall ... http://www.hopeforthewarriors.org/2014LIRun . The run is organized by Hope ...
(Date:9/16/2014)... Alabama (PRWEB) September 16, 2014 *To find ... AL, visit Achieve Clinical Research on the web ( http://www.achieveclinical.com/trial/pneumonia-vaccine/ ... those who qualify:, There is no ... , Compensation may be provided for time ... pneumonia and influenza are the eighth leading cause of death ...
(Date:9/16/2014)... *Anyone who is interested in learning more about ... visit Avail Clinical Research on the web ( http://www.availclinical.com/trial/common-cold/ ... Why Are Volunteers Needed? , The common cold is ... While infections may not be as deadly as in ... visits to the doctor than any other medical condition ...
(Date:9/16/2014)... DC (PRWEB) September 16, 2014 ... civic information media site, launches their new site ... has additional features aimed at making information easier ... we sift, we distill into one-page, easy-to-read pages ... American should know!” says Virginia Downie, retired college ...
Breaking Medicine News(10 mins):Health News:Los Angeles Orthopedic Surgeon Spotlights ACL Conditions With New Website 2Health News:Los Angeles Orthopedic Surgeon Spotlights ACL Conditions With New Website 3Health News:The Hope For The Warriors Long Island Run For The Warriors to Honor Wounded and Families of the Fallen 2Health News:The Team at Achieve Clinical Research is Enrolling Qualified Individuals to Participate in a Pneumonia Vaccine Clinical Trial in Birmingham, Alabama 2Health News:The Team at Achieve Clinical Research is Enrolling Qualified Individuals to Participate in a Pneumonia Vaccine Clinical Trial in Birmingham, Alabama 3Health News:Avail Clinical Research Is Looking for Healthy Adults Who Are Interested in Participating in a Common Cold Clinical Trial near Orlando, Florida 2Health News:Avail Clinical Research Is Looking for Healthy Adults Who Are Interested in Participating in a Common Cold Clinical Trial near Orlando, Florida 3Health News:JustThoughtYouShouldKnow.org Debuts New Website 2
... More than $1.1 billion a year is spent on ... study reports the state has a rising number of people ... hunger. The MU Interdisciplinary Center for Food Security has released ... Missouri Hunger Atlas details the distribution of hunger in the ...
... found remission occurred faster, more often with immunosuppressive ... News) -- Treating Crohn,s disease more aggressively resulted ... of researchers reports. , Using more than one ... with the disease was more effective in inducing ...
... 22 The Cleveland Department of,Health and Cincinnati ... to fund community lead poisoning prevention projects.,U.S. Environmental ... of a,national goal to eliminate childhood lead poisoning ... The Cleveland Department of Health received $99,990 to ...
... NexGen Biofuels Ltd.,(NASDAQ: NXGN ) (the "Company") ... The company has changed its name on January 28, ... more clearly reflect its new business, which,is to pursue ... through the acquisition of existing production facilities and/or,through the ...
... Health is creating a,network of more than 3,000 ... providing patients with more convenient access to,consistently high-quality ... a presence in dozens of cities and towns ... Central Valley and from Santa Cruz,to the Mother ...
... YORK, Feb. 22 The Physicians Coalition,for Injectable ... on,the safety of Botox(R) injections after reports of ... "Consumers who have had Botox(R) injections for ... indications should not be alarmed,by recent reports of ...
Cached Medicine News:Health News:MU research team releases first Missouri Hunger Atlas 2Health News:Aggressive Therapy for Crohn's Disease Produces Better Outcomes 2Health News:Aggressive Therapy for Crohn's Disease Produces Better Outcomes 3Health News:Sutter Health Launches Northern California Physician Network 2Health News:Sutter Health Launches Northern California Physician Network 3Health News:Clarity for Consumers on Botox Complication and Death Reports 2Health News:Clarity for Consumers on Botox Complication and Death Reports 3Health News:Clarity for Consumers on Botox Complication and Death Reports 4
... Screen Panel is used for the rapid detection of ... Panel consists of a test cup and test card. ... inserted and the sample sealed with a lid. Results ... to remove the test card to read the result. ...
Detect LH surge for predicting ovulation, Able to detect as low as 40 mIU/mL LH or 30 mIU/mL LH, Simple, easy and accurate, Built-in control system...
... Hemoglobin Test Systems provide ... quantitative hemoglobin results with ... a large hematology analyzer. ... of either the B-Hemoglobin ...
... Chemstrip Micral test strips are an ... in urine samples. When the test ... sample, urine passes via a wick ... albumin present in the sample binds ...
Medicine Products: